Publication

Article

BioPharm International

BioPharm International-05-15-2017
Volume2017 eBook
Issue 1
Pages: s8-s14

Key Considerations in Outsourced “On-Site” Audits as Part of Supplier Qualification

This article reviews experiences with the outcome of in-house audits, audits by third parties, and purchased audit reports.

A pharmaceutical manufacturer can perform its own audits as part of supplier qualification; or authorize a suitable third-party audit provider to perform the audit on its behalf; or buy an audit report from a commercial provider. The main focus of interest is the final audit report, which in any case, should be written informatively and distinctly, and should enable the reader to gain a comprehensive impression of the audited firm. This article reports some experiences with the outcome of in-house audits, audits by third parties, and purchased audit reports.

 

Download BioPharm International's

2017 Outsourcing Resources eBook

.

 

 

 

 

Newsletter

Stay at the forefront of biopharmaceutical innovation—subscribe to BioPharm International for expert insights on drug development, manufacturing, compliance, and more.

Related Videos
Behind the Headlines, Episode 23: Patent Cliff Deals, Tariff Pressures, and the In Vivo Cell Therapy Bet
© 2025 MJH Life Sciences

All rights reserved.